Status:
WITHDRAWN
Use of the Hattler Respiratory Assist Catheter in Severe Respiratory Failure
Lead Sponsor:
Alung Technologies
Conditions:
Emphysema
Acute Respiratory Distress Syndrome
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
A new artificial lung device has been developed that potentially provides added support to mechanical ventilation for severely damaged lungs. The Hattler Respiratory Assist Catheter is designed to pro...
Detailed Description
The Hattler Catheter Respiratory Assist Device consists of a Catheter and a drive console. The catheter consists of a bundle of polypropylene hollow fibers (approximately 1000) in 30cm or 35cm length ...
Eligibility Criteria
Inclusion
- Both sexes, 18 years and older
- Have a terminally ill disease process
- On maximum ventilator support
- Intubated and unconscious
- Swan Ganz in place
- Hypoxic
- Unsuitable for organ donation
Exclusion
- Circulatory shock (\< 80 mmHg) and unresponsive to drug therapy and volume replacement
- Pregnancy
- Morbid obesity \> 182 kg
- Weight \< 41 kg
- History of bleeding disorders with contraindication to heparin
- Have a disease process with a contraindication to heparin
- Known internal jugular or femoral vein complications or abnormalities
- Known inferior vena cava (IVC) filter in place
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00288964
Start Date
November 1 2005
Last Update
December 29 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Papworth Hospital NHS Trust
Papworth Everard, Cambridge, United Kingdom, CB3 8RE